Biologic tumor behavior in pilocytic astrocytomas.

Area of Science:

• Neuro-oncology
• Molecular pathology
• Genetics

Background:

• Pilocytic astrocytoma (PA) is the most common pediatric brain tumor.
• Understanding PA behavior and prognosis is crucial for effective treatment strategies.

Purpose of the Study:

• To investigate the behavior of pilocytic astrocytoma (PA) using flow cytometry, immunohistochemistry, and cytogenetics.
• To determine the impact of PA localization on prognosis and molecular characteristics.
• To identify potential prognostic markers in PA.

Main Methods:

• Analysis of DNA index, p53, p16, pRb, MMAC/PTEN1, VEGF, and MIB-1 expression in 53 PA samples.
• Detection of chromosomal anomalies using array comparative genomic hybridization (CGH).
• Correlation of molecular findings with clinical prognosis and tumor location (cerebellar, chiasmatic/hypothalamic, hemispheric).

Main Results:

• PAs were predominantly diploid, with ploidy not affecting prognosis.
• Expression of p53, p16, pRb, MMAC/PTEN1, and VEGF did not differ significantly by location or predict prognosis.
• Frequent copy number aberrations (CNAs) were observed, with specific amplifications (e.g., 2p11.2, 9p11.2) and deletions (e.g., 1p36.21) correlating with prognosis.
• A significant correlation was found between 16p11.2 amplification and tumor localization.

Conclusions:

• Differently localized PAs exhibit distinct biological properties influencing aggressiveness.
• High-resolution analysis reveals significant copy number aberrations in PAs.
• Tumor suppressor gene expression (p53, p16, pRb, MMAC/PTEN1) does not appear to play a significant role in PA pathogenesis or prognosis.